96.2
Lisata Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
71.9
FY23:
53.9
FY24:
34.6
FY25:
17.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.83
FY22:
1.16
FY23:
0.77
FY24:
0.42
FY25:
0.04
Total assets
Change from FY21 to FY25
millions USD
FY21:
97.0
FY22:
73.0
FY23:
54.7
FY24:
35.0
FY25:
17.7
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.52
FY22:
6.38
FY23:
6.59
FY24:
5.61
FY25:
3.07
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.49
FY22:
0.33
FY23:
0.21
FY24:
0.07
FY25:
0.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
92.3
FY22:
66.6
FY23:
48.1
FY24:
29.6
FY25:
14.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
97.3
FY22:
73.3
FY23:
54.9
FY24:
35.3
FY25:
18.0
All amounts in millions USD